James C. Hamilton, Chief Medical Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 40,164 shares at $61.24 ($2.5M) on 2026-01-05, disclosed to the SEC on 2026-01-05.
Seasonal sale ($2.5M) by Chief Medical Officer — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.24 | 4,625 | $283K | 11.2% |
| 2 | $62.28 | 6,090 | $379K | 15.0% |
| 3 | $63.01 | 14,792 | $932K | 36.8% |
| 4 | $63.95 | 12,711 | $813K | 32.1% |
| 5 | $64.49 | 1,200 | $77K | 3.1% |
| 6 | $65.97 | 437 |
| $29K |
| 1.1% |
| 7 | $68.00 | 309 | $21K | 0.8% |
| Total | $63.11 avg | 40,164 | $2.5M | 100% |
| Filing → |
| ARWR | SELL | 2025-10-03 | $700K | — | Filing → |
| ARWR | SELL | 2025-09-16 | $450K | — | Filing → |
| ARWR | SELL | 2025-09-04 | $375K | — | Filing → |